MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-34-0003166
Gadiya Pharmaceuticals Private Limited - pharma in Chengalpattu, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹23.04 Cr
▲ 1% YoY
Net profit · FY 2024
₹12,878
Net margin 0%
EBITDA · FY 2024
₹16.84 Lakh
EBITDA margin 0.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Satisfied charges
₹1.5 Cr
No open charges
Company age
33 yrs
Est. 1993
Employees · EPFO
16
Provident fund records
About Gadiya Pharmaceuticals Private Limited
Data last updated:
Gadiya Pharmaceuticals Private Limited is a private limited company based in Chengalpattu, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 October 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN1993PTC025984. Its GSTIN is 33AAACG2263N1ZN (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Jitendra Kumar and Surendra Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 107 Periyar Street(Big Chetty Street) Chengalpattu – 603 001., Tamil Nadu, India – 603001.
As per the financials filed for FY 2024, the company reported a revenue of ₹23.04 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹12,878 (net margin 0%) and EBITDA of ₹16.84 Lakh (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 7% over five years.
The company has about 16 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹1.5 Cr on record.
Gadiya Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-34-0003166). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gadiya.wsweborder.com.
Company details
CIN U24231TN1993PTC025984
Registration Number 025984
Incorporation Date 12 October 1993
ROC Chennai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-34-0003166
Key People
Jitendra Kumar Director Surendra Kumar Director Recognitions & Rankings of Gadiya Pharmaceuticals
Contact details
Gadiya Pharmaceuticals Private Limited's registered office is in Chengalpattu, Tamil Nadu. Its website is gadiya.wsweborder.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address107 Periyar Street(Big Chetty Street) Chengalpattu – 603 001., Tamil Nadu, India – 603001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Gadiya Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Gadiya Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Gadiya Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Gadiya Pharmaceuticals Private Limited, buy the company report.
Financials of Gadiya Pharmaceuticals Private Limited
FY 2025 filings availableGadiya Pharmaceuticals Private Limited reported revenue of ₹23.04 Cr (up 1% YoY) for FY 2024.
Revenue · FY 2024
₹23.04 Cr ▲ 1%
Net profit · FY 2024
₹12,878 margin 0%
EBITDA · FY 2024
₹16.84 Lakh margin 0.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 2%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▼ 13%
3 years · compounded
▼ 16%
5 years · compounded
▼ 6%
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 1% growth in the latest year. EBITDA fell 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.84 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12,878 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gadiya Pharmaceuticals Private Limited, buy the company report.
Board of directors of Gadiya Pharmaceuticals Private Limited
Gadiya Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jitendra Kumar | Director | 12 Oct 1993 | 33 Years 1 Months | Current |
| Surendra Kumar | Director | 12 Oct 1993 | 33 Years 1 Months | Current |
Peer comparison
Gadiya Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fourbro Pharma Distributor Private Limited | ₹23.08 Cr (FY 2025) | 3.0% | Kolkata, West Bengal, India | |||
| Medroute Pharmaceuticals Private Limited | ₹23.07 Cr (FY 2025) | -67.0% | Hoshiarpur, Punjab, India | |||
| Gadiya Pharmaceuticals Private Limitedthis company | ₹23.04 Cr (FY 2024) | ₹12,878 | 0% | 1.0% | 16 | Chengalpattu, Tamil Nadu, India |
| Zeal Medipharma (Export) Private Limited | ₹22.94 Cr (FY 2025) | -7.0% | Thane, Maharashtra, India | |||
| Vertech Health Solutions India Private Limited | ₹22.89 Cr (FY 2025) | 11.0% | New Delhi, Delhi, India | |||
| Bareilly Pharmaceuticals Private Limited | ₹22.81 Cr (FY 2024) | 7.0% | Bareilly, Uttar Pradesh, India |
To see the full peer comparison of Gadiya Pharmaceuticals Private Limited, buy the company report.
Auditor
Gadiya Pharmaceuticals Private Limited is audited by P M CHORDIA & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P M CHORDIA & CO. | FY 2022 | 000651S |
Shareholding
The shareholding of Gadiya Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Gadiya Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹1.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Jan 2012 | 10330737 | Indian Bank | ₹1.5 Cr | Satisfied |
To see the full charge records of Gadiya Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Gadiya Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gadiya Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Gadiya Pharmaceuticals Private Limited has a workforce of 16 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
16
Active EPFO establishments
1
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 16 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Gadiya Pharmaceuticals Private Limited, buy the company report.
GST
Gadiya Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAACG2263N1ZN | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Gadiya Pharmaceuticals Private Limited, buy the company report.
Recent activity
Gadiya Pharmaceuticals Private Limited has 3 board changes on record since 1993: 2 appointments and 1 cessation. The latest: Prasannamal Kaluram Chunnilal ceased to be Director on 29 Sep 2012.
AGM
Gadiya Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Gadiya Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge registered on 02 Jan 2012 via Charge ID 10330737 with Indian Bank was fully satisfied on 03 Jan 2024.
Charges
A charge with Indian Bank of Rs. 150.00 Lakh registered on 02 Jan 2012 with Charge ID 10330737 was modified on 17 Feb 2020.
Ceased
Prasannamal Kaluram Chunnilal ceased to be Director.
Charges
A charge with Indian Bank amounted to Rs. 150.00 Lakh with Charge ID 10330737 was registered on 02 Jan 2012.
Appointed
Jitendra Kumar was appointed as Director.
Appointed
Surendra Kumar was appointed as Director.
Incorporation
12 Oct 1993
Gadiya Pharmaceuticals Private Limited was registered on 12 Oct 1993 with Roc Chennai & aged 33 years 1 month as per MCA records.
Frequently asked questions
Gadiya Pharmaceuticals is an active private limited company based in Chengalpattu, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 October 1993 (33+ years old) and is registered under CIN U24231TN1993PTC025984.
Gadiya Pharmaceuticals has 2 current directors:
- Jitendra Kumar - Director
- Surendra Kumar - Director
The latest financial statements of Gadiya Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Gadiya Pharmaceuticals is 33AAACG2263N1ZN, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Gadiya Pharmaceuticals is U24231TN1993PTC025984. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gadiya Pharmaceuticals was incorporated on 12 October 1993, making it 33+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Gadiya Pharmaceuticals by revenue are Fourbro Pharma Distributor Private Limited, Medroute Pharmaceuticals Private Limited, Zeal Medipharma (Export) Private Limited, Vertech Health Solutions India Private Limited, Bareilly Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Prasannamal Kaluram Chunnilal ceased to be Director on 29 Sep 2012. Jitendra Kumar was appointed as Director on 12 Oct 1993. Surendra Kumar was appointed as Director on 12 Oct 1993.
Yes, Gadiya Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-TN-34-0003166).
Gadiya Pharmaceuticals can be reached through the website gadiya.wsweborder.com. Its registered office is in Chengalpattu, Tamil Nadu, India.
The registered office of Gadiya Pharmaceuticals is at 107 Periyar StreetBig Chetty Street Chengalpattu – 603 001., Tamil Nadu, India – 603001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages